Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -85.95x is in line with its 1-year average of -82.67x, around the middle of its 1-year range (-126.31x–-45.17x).
5.53% below its 12-month average of -81.44x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -100.62x.
INTEREST COVERAGE RATIO
-85.95x
INTEREST COVERAGE RATIO AVG TTM
-81.44x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.53%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 441 covered companies
CURRENT VS SECTOR MEDIAN
-1426.64%
vs the sector median at left
Cabaletta Bio, Inc.
Market Cap
$335.08M
Interest Coverage Ratio
-85.95x
TTM Avg
-81.44x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$332.28M
Interest Coverage Ratio
-10.12x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$339.48M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
Market Cap
$321.20M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$318.73M
Interest Coverage Ratio
-8.50x
TTM Avg
39.51x
3Y Avg
19.80x
5Y Avg
13.45x
Market Cap
$353.90M
Interest Coverage Ratio
-45.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$354.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$356.17M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $335.08M | -85.95x | -81.44x | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $332.28M | -10.12x | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $339.48M | -0.37x | 0.39x | 0.39x | 0.39x |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.20M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $319.27M | N/A | N/A | N/A | N/A |
| Avita Medical Inc. (RCEL)vs › | $318.73M | -8.50x | 39.51x | 19.80x | 13.45x |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.90M | -45.13x | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $354.45M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $356.17M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Embecta Corp. (EMBC)vs › | $356.26M | 3.07x | 2.31x | 3.74x | 3.74x |
Interest Coverage
-86.0x
Debt/Equity
0.12
Current Ratio
5.79
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -100.62x |
| 2026-03-31 | -69.65x |
| 2025-12-31 | -76.78x |
| 2025-09-30 | -79.77x |
| 2025-06-30 | -80.40x |
| 2025-03-31 | -126.31x |
| 2024-12-31 | -45.17x |
